Antibiotics-why so many and when should we use them?

Area of Science:

• Vascular Surgery
• Infectious Disease
• Pharmacology

Background:

• Surgical site infections (SSIs) are a significant complication in vascular surgery.
• Prophylactic antibiotics are crucial for preventing SSIs in various vascular procedures.
• Emerging applications of antibiotics show potential in managing vascular disease progression.

Purpose of the Study:

• To summarize current recommendations for antibiotic prophylaxis in vascular surgery.
• To outline strategies for treating established vascular graft infections.
• To explore novel antibiotic applications in vascular disease management.

Main Methods:

• Review of current guidelines and literature on antibiotic prophylaxis and treatment in vascular surgery.
• Discussion of recommended antibiotic agents, dosages, and durations.
• Exploration of adjunctive therapies like rifampin-soaked grafts.
• Examination of new antibiotic applications targeting matrix metalloproteinases and inflammation.

Main Results:

• Cefazolin or cefuroxime for 1-2 days is recommended for prophylaxis, with vancomycin added if methicillin-resistant Staphylococcus aureus is prevalent.
• Rifampin-soaked grafts can decrease infection rates in high-risk patients.
• Treatment of established infections requires broad-spectrum coverage initially, followed by culture-specific therapy.
• Tetracyclines like doxycycline and azithromycin show promise in managing aortic aneurysms and atherogenesis.

Conclusions:

• Appropriate antibiotic prophylaxis and treatment are essential for reducing SSIs and managing vascular graft infections.
• Novel antibiotic strategies offer potential for disease modification in vascular conditions.
• Balancing antibiotic efficacy, side effects, and cost is critical in clinical decision-making.